592 related articles for article (PubMed ID: 33599163)
1. Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Systematic Review of the Literature and Challenges.
Patel RH; Acharya A; Chand HS; Mohan M; Byrareddy SN
AIDS Res Hum Retroviruses; 2021 Apr; 37(4):266-282. PubMed ID: 33599163
[TBL] [Abstract][Full Text] [Related]
2. HIV and COVID-19: review of clinical course and outcomes.
Barbera LK; Kamis KF; Rowan SE; Davis AJ; Shehata S; Carlson JJ; Johnson SC; Erlandson KM
HIV Res Clin Pract; 2021 Aug; 22(4):102-118. PubMed ID: 34514963
[No Abstract] [Full Text] [Related]
3. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
Viruses; 2021 May; 13(5):. PubMed ID: 34067925
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of COVID-19 amongst HIV patients: a systematic literature review.
Massarvva T
Epidemiol Health; 2021; 43():e2021036. PubMed ID: 34015893
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Virologic and Immunologic Outcomes for HIV Patients With Coronavirus Disease 2019.
Hu R; Yan H; Liu M; Tang L; Kong W; Zhu Z; Liu P; Bai W; Hu X; Ding J; Wang X; Xie N
J Acquir Immune Defic Syndr; 2021 Feb; 86(2):213-218. PubMed ID: 33079905
[TBL] [Abstract][Full Text] [Related]
6. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
Dutta D; Liu J; Xiong H
Viruses; 2023 May; 15(5):. PubMed ID: 37243203
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis.
Ssentongo P; Heilbrunn ES; Ssentongo AE; Advani S; Chinchilli VM; Nunez JJ; Du P
Sci Rep; 2021 Mar; 11(1):6283. PubMed ID: 33737527
[TBL] [Abstract][Full Text] [Related]
8. The Interrelationship between HIV Infection and COVID-19: A Review of the Literature.
Wang Y; Lai Y
Curr HIV Res; 2024; 22(1):6-15. PubMed ID: 38151836
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
Del Amo J; Polo R; Moreno S; Jarrín I; Hernán MA
AIDS; 2022 Feb; 36(2):161-168. PubMed ID: 34934017
[TBL] [Abstract][Full Text] [Related]
10. Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2.
Yan D; Yan B
Curr Drug Metab; 2023; 24(4):240-249. PubMed ID: 37287302
[TBL] [Abstract][Full Text] [Related]
11. Presentation and outcome of COVID-19 in HIV patients with high viral loads and opportunistic infections: a case series.
Hardy YO; Amenuke DA; Hutton-Mensah KA; Chadwick DR; Larsen-Reindorf R
Ghana Med J; 2020 Dec; 54(4 Suppl):121-124. PubMed ID: 33976453
[TBL] [Abstract][Full Text] [Related]
12. Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Augello M; Bono V; Rovito R; Tincati C; Marchetti G
Curr HIV/AIDS Rep; 2023 Apr; 20(2):51-75. PubMed ID: 36680700
[TBL] [Abstract][Full Text] [Related]
13. The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.
Johnston R
Curr Opin HIV AIDS; 2021 Jan; 16(1):54-62. PubMed ID: 33165007
[TBL] [Abstract][Full Text] [Related]
14. Stability analysis of within-host SARS-CoV-2/HIV coinfection model.
Al Agha AD; Elaiw AM; Azoz SA; Ramadan E
Math Methods Appl Sci; 2022 Jun; ():. PubMed ID: 35942149
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccines for HIV-Infected Patients.
Plummer MM; Pavia CS
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696319
[TBL] [Abstract][Full Text] [Related]
16. Curating a knowledge base for individuals with coinfection of HIV and SARS-CoV-2: a study protocol of EHR-based data mining and clinical implementation.
Liang C; Weissman S; Olatosi B; Poon EG; Yarrington ME; Li X
BMJ Open; 2022 Sep; 12(9):e067204. PubMed ID: 36100301
[TBL] [Abstract][Full Text] [Related]
17. Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland.
Kowalska JD; Lara M; Hlebowicz M; Mularska E; Jabłonowska E; Siwak E; Wandałowicz A; Witak-Jędra M; Olczak A; Bociąga-Jasik M; Suchacz M; Stempkowska-Rejek J; Wasilewski P; Parczewski M
Infection; 2023 Apr; 51(2):379-387. PubMed ID: 35882773
[TBL] [Abstract][Full Text] [Related]
18. Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic.
Montano M
AIDS Res Hum Retroviruses; 2021 Aug; 37(8):589-600. PubMed ID: 33587013
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Study of Outcomes Among Persons With HIV Who Presented to US Emergency Departments With Suspected SARS-CoV-2.
Bennett CL; Ogele E; Pettit NR; Bischof JJ; Meng T; Govindarajan P; Camargo CA; Nordenholz K; Kline JA;
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):406-413. PubMed ID: 34483295
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH).
Gutierrez MDM; Mur I; Mateo MG; Vidal F; Domingo P
Expert Opin Pharmacother; 2021 Jun; 22(9):1127-1141. PubMed ID: 33634724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
